Dyax Corp, BioCryst Pharma Lead Tuesday's After-Hours Movers

By: via Benzinga
Dyax Corp. (NASDAQ: DYAX) jumped nearly 49 percent to $24.90 a share in late trading Tuesday after the company said a Phase Ib trial ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.